 Brandie Wagner
Concepts (618)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis | 36 | 2023 | 955 | 3.910 |
Why?
| | Microbiota | 23 | 2024 | 647 | 2.780 |
Why?
| | Bronchopulmonary Dysplasia | 10 | 2020 | 329 | 2.320 |
Why?
| | Pseudomonas Infections | 6 | 2023 | 184 | 2.210 |
Why?
| | Infant, Premature | 12 | 2019 | 476 | 2.110 |
Why?
| | Macular Degeneration | 8 | 2023 | 152 | 1.840 |
Why?
| | Retinopathy of Prematurity | 10 | 2020 | 111 | 1.800 |
Why?
| | Hypertension, Pulmonary | 11 | 2023 | 1728 | 1.270 |
Why?
| | Bacteria | 15 | 2023 | 725 | 1.200 |
Why?
| | Retinal Drusen | 3 | 2021 | 25 | 1.090 |
Why?
| | RNA, Ribosomal, 16S | 15 | 2023 | 485 | 1.090 |
Why?
| | Lung | 21 | 2024 | 3558 | 1.080 |
Why?
| | Trachea | 4 | 2023 | 224 | 1.080 |
Why?
| | Gastrointestinal Microbiome | 9 | 2021 | 501 | 1.020 |
Why?
| | Anti-Bacterial Agents | 13 | 2024 | 1477 | 0.990 |
Why?
| | Birth Weight | 7 | 2020 | 440 | 0.960 |
Why?
| | Premature Birth | 5 | 2017 | 276 | 0.890 |
Why?
| | Geographic Atrophy | 5 | 2023 | 49 | 0.880 |
Why?
| | Respiratory Tract Infections | 7 | 2024 | 319 | 0.870 |
Why?
| | Humans | 148 | 2024 | 114624 | 0.840 |
Why?
| | Sputum | 12 | 2023 | 285 | 0.830 |
Why?
| | Weight Gain | 5 | 2019 | 453 | 0.800 |
Why?
| | Infant, Newborn | 28 | 2023 | 5043 | 0.800 |
Why?
| | Gestational Age | 17 | 2020 | 759 | 0.790 |
Why?
| | Female | 102 | 2023 | 59466 | 0.780 |
Why?
| | Echocardiography, Doppler | 3 | 2018 | 91 | 0.750 |
Why?
| | Models, Statistical | 5 | 2016 | 599 | 0.740 |
Why?
| | Male | 91 | 2023 | 55555 | 0.700 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2022 | 590 | 0.700 |
Why?
| | Diabetic Retinopathy | 4 | 2023 | 149 | 0.690 |
Why?
| | Heart Diseases | 1 | 2023 | 331 | 0.680 |
Why?
| | Inflammation | 15 | 2023 | 2478 | 0.670 |
Why?
| | Child | 52 | 2024 | 18404 | 0.660 |
Why?
| | Schizophrenia | 7 | 2017 | 414 | 0.660 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 216 | 0.630 |
Why?
| | Down Syndrome | 1 | 2023 | 335 | 0.610 |
Why?
| | Proteomics | 10 | 2023 | 836 | 0.610 |
Why?
| | Phacoemulsification | 4 | 2023 | 107 | 0.590 |
Why?
| | Biomarkers | 19 | 2023 | 3408 | 0.550 |
Why?
| | Risk Assessment | 6 | 2019 | 2967 | 0.550 |
Why?
| | Cataract | 5 | 2023 | 185 | 0.530 |
Why?
| | Vascular Diseases | 2 | 2020 | 230 | 0.520 |
Why?
| | Prospective Studies | 23 | 2023 | 6217 | 0.520 |
Why?
| | Infant, Very Low Birth Weight | 5 | 2019 | 66 | 0.520 |
Why?
| | Statistical Distributions | 1 | 2015 | 7 | 0.510 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2015 | 35 | 0.500 |
Why?
| | Intestines | 3 | 2014 | 326 | 0.500 |
Why?
| | Blood Proteins | 2 | 2015 | 231 | 0.500 |
Why?
| | Neonatal Screening | 4 | 2018 | 152 | 0.490 |
Why?
| | Islets of Langerhans | 4 | 2015 | 726 | 0.490 |
Why?
| | Infant | 25 | 2023 | 7959 | 0.470 |
Why?
| | Respiratory System | 4 | 2018 | 137 | 0.470 |
Why?
| | Coronary Artery Disease | 1 | 2020 | 607 | 0.460 |
Why?
| | Complement Factor B | 3 | 2022 | 100 | 0.460 |
Why?
| | Respiratory Function Tests | 9 | 2020 | 522 | 0.460 |
Why?
| | Pseudomonas aeruginosa | 6 | 2023 | 298 | 0.450 |
Why?
| | Visual Acuity | 5 | 2023 | 274 | 0.440 |
Why?
| | Coronary Artery Bypass | 3 | 2020 | 196 | 0.440 |
Why?
| | Case-Control Studies | 17 | 2023 | 3003 | 0.430 |
Why?
| | Risk Factors | 19 | 2020 | 8628 | 0.430 |
Why?
| | Azithromycin | 3 | 2023 | 80 | 0.410 |
Why?
| | Pregnancy | 14 | 2019 | 5517 | 0.410 |
Why?
| | Algorithms | 5 | 2018 | 1466 | 0.400 |
Why?
| | Stroke | 1 | 2020 | 1021 | 0.390 |
Why?
| | Disease Progression | 10 | 2022 | 2380 | 0.390 |
Why?
| | Adolescent | 36 | 2023 | 17831 | 0.380 |
Why?
| | Sequence Analysis | 1 | 2011 | 35 | 0.380 |
Why?
| | Retrospective Studies | 27 | 2023 | 12542 | 0.370 |
Why?
| | Hemodynamics | 4 | 2013 | 1012 | 0.370 |
Why?
| | Eczema | 1 | 2012 | 81 | 0.370 |
Why?
| | Respiratory System Agents | 2 | 2022 | 22 | 0.360 |
Why?
| | Cohort Studies | 17 | 2022 | 4894 | 0.350 |
Why?
| | Body Mass Index | 6 | 2019 | 1956 | 0.350 |
Why?
| | Lung Diseases, Interstitial | 4 | 2019 | 507 | 0.350 |
Why?
| | Aminophenols | 2 | 2022 | 112 | 0.340 |
Why?
| | Intraocular Pressure | 4 | 2018 | 276 | 0.330 |
Why?
| | Complement Activation | 3 | 2022 | 340 | 0.320 |
Why?
| | Bronchiectasis | 2 | 2023 | 106 | 0.320 |
Why?
| | Wet Macular Degeneration | 2 | 2019 | 32 | 0.320 |
Why?
| | Young Adult | 22 | 2022 | 10455 | 0.310 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1002 | 0.310 |
Why?
| | Anti-Inflammatory Agents | 3 | 2021 | 447 | 0.310 |
Why?
| | Staphylococcus | 3 | 2017 | 69 | 0.310 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2015 | 3244 | 0.310 |
Why?
| | Hypersensitivity | 1 | 2012 | 252 | 0.310 |
Why?
| | Creatinine | 1 | 2010 | 425 | 0.310 |
Why?
| | Respiratory Tract Diseases | 2 | 2020 | 138 | 0.310 |
Why?
| | Infant, Extremely Premature | 2 | 2020 | 57 | 0.300 |
Why?
| | Critical Illness | 5 | 2024 | 644 | 0.300 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 72 | 0.290 |
Why?
| | Neuroendocrine Cells | 4 | 2019 | 30 | 0.290 |
Why?
| | Data Interpretation, Statistical | 2 | 2016 | 321 | 0.290 |
Why?
| | Mental Disorders | 1 | 2015 | 892 | 0.290 |
Why?
| | Fetal Membranes, Premature Rupture | 2 | 2017 | 34 | 0.290 |
Why?
| | DNA, Bacterial | 6 | 2021 | 311 | 0.280 |
Why?
| | Substance-Related Disorders | 1 | 2015 | 947 | 0.280 |
Why?
| | Lens Implantation, Intraocular | 2 | 2018 | 57 | 0.280 |
Why?
| | Cytokines | 7 | 2023 | 1840 | 0.280 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2009 | 740 | 0.270 |
Why?
| | Obesity | 4 | 2019 | 2507 | 0.270 |
Why?
| | Postoperative Complications | 5 | 2023 | 2128 | 0.270 |
Why?
| | Bacterial Infections | 2 | 2020 | 218 | 0.260 |
Why?
| | Mycobacterium Infections, Nontuberculous | 2 | 2023 | 333 | 0.260 |
Why?
| | Follow-Up Studies | 10 | 2021 | 4411 | 0.260 |
Why?
| | Aged | 17 | 2023 | 19061 | 0.260 |
Why?
| | Software | 3 | 2021 | 529 | 0.260 |
Why?
| | Choline | 2 | 2019 | 106 | 0.250 |
Why?
| | Chemokine CCL5 | 2 | 2023 | 45 | 0.250 |
Why?
| | Glaucoma | 2 | 2018 | 202 | 0.250 |
Why?
| | Linear Models | 3 | 2018 | 768 | 0.250 |
Why?
| | Rheumatoid Factor | 3 | 2023 | 157 | 0.250 |
Why?
| | Adult | 31 | 2024 | 30528 | 0.250 |
Why?
| | Tobramycin | 2 | 2023 | 47 | 0.240 |
Why?
| | Child, Preschool | 18 | 2021 | 9108 | 0.240 |
Why?
| | Pre-Eclampsia | 2 | 2017 | 165 | 0.240 |
Why?
| | Sensory Gating | 2 | 2016 | 38 | 0.230 |
Why?
| | Hyperplasia | 4 | 2019 | 163 | 0.230 |
Why?
| | Intestinal Mucosa | 3 | 2015 | 532 | 0.230 |
Why?
| | Pseudomonas | 2 | 2022 | 26 | 0.230 |
Why?
| | Lung Diseases | 2 | 2023 | 701 | 0.230 |
Why?
| | Survival Rate | 3 | 2020 | 1644 | 0.230 |
Why?
| | Gastrointestinal Tract | 2 | 2019 | 169 | 0.220 |
Why?
| | Macula Lutea | 1 | 2023 | 15 | 0.220 |
Why?
| | Pneumonia | 3 | 2017 | 567 | 0.220 |
Why?
| | Benzylidene Compounds | 2 | 2017 | 17 | 0.220 |
Why?
| | Societies | 1 | 2023 | 38 | 0.220 |
Why?
| | Longitudinal Studies | 7 | 2020 | 2387 | 0.220 |
Why?
| | Hippocampus | 1 | 2008 | 693 | 0.220 |
Why?
| | Vitreous Body | 2 | 2022 | 101 | 0.220 |
Why?
| | Respiration, Artificial | 4 | 2023 | 529 | 0.220 |
Why?
| | Methylprednisolone | 1 | 2023 | 81 | 0.210 |
Why?
| | Optic Neuritis | 1 | 2023 | 37 | 0.210 |
Why?
| | Retinal Detachment | 1 | 2023 | 53 | 0.210 |
Why?
| | Ciliary Motility Disorders | 1 | 2023 | 21 | 0.210 |
Why?
| | ROC Curve | 3 | 2019 | 442 | 0.210 |
Why?
| | Diabetes Mellitus | 3 | 2022 | 900 | 0.200 |
Why?
| | Treatment Outcome | 11 | 2023 | 9084 | 0.200 |
Why?
| | Colorado | 11 | 2022 | 4099 | 0.200 |
Why?
| | Middle Aged | 22 | 2023 | 26719 | 0.200 |
Why?
| | Anti-Citrullinated Protein Antibodies | 2 | 2020 | 90 | 0.200 |
Why?
| | Mothers | 5 | 2019 | 651 | 0.200 |
Why?
| | Congresses as Topic | 1 | 2023 | 195 | 0.200 |
Why?
| | Aspergillosis, Allergic Bronchopulmonary | 1 | 2021 | 9 | 0.200 |
Why?
| | Administration, Inhalation | 1 | 2023 | 641 | 0.200 |
Why?
| | Natriuretic Peptide, Brain | 3 | 2012 | 94 | 0.200 |
Why?
| | Smoking | 3 | 2018 | 1380 | 0.190 |
Why?
| | Posterior Capsulotomy | 1 | 2021 | 7 | 0.190 |
Why?
| | Posterior Capsule of the Lens | 1 | 2021 | 10 | 0.190 |
Why?
| | Fluorescein Angiography | 4 | 2023 | 102 | 0.190 |
Why?
| | Lens Capsule, Crystalline | 1 | 2021 | 9 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 160 | 0.190 |
Why?
| | Capsule Opacification | 1 | 2021 | 20 | 0.190 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1518 | 0.190 |
Why?
| | Ethambutol | 1 | 2021 | 20 | 0.190 |
Why?
| | Lasers, Solid-State | 1 | 2021 | 22 | 0.190 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2022 | 60 | 0.190 |
Why?
| | Complement System Proteins | 2 | 2022 | 283 | 0.190 |
Why?
| | Desmosine | 2 | 2012 | 6 | 0.180 |
Why?
| | Genetic Predisposition to Disease | 5 | 2019 | 2084 | 0.180 |
Why?
| | Glycation End Products, Advanced | 1 | 2021 | 57 | 0.180 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 3 | 2017 | 96 | 0.180 |
Why?
| | Area Under Curve | 2 | 2019 | 274 | 0.180 |
Why?
| | Dementia | 1 | 2023 | 187 | 0.180 |
Why?
| | Rifampin | 1 | 2021 | 68 | 0.180 |
Why?
| | Acetaldehyde | 1 | 2020 | 15 | 0.180 |
Why?
| | Malondialdehyde | 1 | 2020 | 28 | 0.180 |
Why?
| | Trabeculectomy | 2 | 2018 | 65 | 0.180 |
Why?
| | Dysbiosis | 2 | 2021 | 146 | 0.180 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2021 | 313 | 0.180 |
Why?
| | Rhodospirillaceae | 1 | 2020 | 4 | 0.180 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 40 | 0.180 |
Why?
| | Neural Inhibition | 2 | 2013 | 140 | 0.180 |
Why?
| | Oropharynx | 3 | 2015 | 36 | 0.180 |
Why?
| | Metagenomics | 3 | 2023 | 131 | 0.180 |
Why?
| | Aged, 80 and over | 9 | 2023 | 6344 | 0.180 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2021 | 63 | 0.180 |
Why?
| | Laser Therapy | 1 | 2021 | 100 | 0.170 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 217 | 0.170 |
Why?
| | Pyridines | 2 | 2017 | 425 | 0.170 |
Why?
| | Angiogenic Proteins | 1 | 2020 | 18 | 0.170 |
Why?
| | Metagenome | 4 | 2013 | 122 | 0.170 |
Why?
| | Retinal Neovascularization | 1 | 2019 | 20 | 0.170 |
Why?
| | Infant, Low Birth Weight | 2 | 2017 | 125 | 0.170 |
Why?
| | Diagnostic Techniques, Ophthalmological | 2 | 2018 | 36 | 0.170 |
Why?
| | Growth Charts | 1 | 2019 | 14 | 0.170 |
Why?
| | Nontuberculous Mycobacteria | 2 | 2023 | 204 | 0.170 |
Why?
| | Heart | 1 | 2023 | 612 | 0.160 |
Why?
| | Sequence Analysis, DNA | 5 | 2015 | 723 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2022 | 286 | 0.160 |
Why?
| | Complement Membrane Attack Complex | 1 | 2019 | 33 | 0.160 |
Why?
| | Complement C3a | 1 | 2019 | 33 | 0.160 |
Why?
| | Staphylococcus aureus | 3 | 2021 | 385 | 0.160 |
Why?
| | Feces | 3 | 2018 | 373 | 0.160 |
Why?
| | Anthropometry | 1 | 2019 | 182 | 0.160 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 42 | 0.160 |
Why?
| | Estrogen Replacement Therapy | 1 | 2019 | 116 | 0.160 |
Why?
| | Choroidal Neovascularization | 1 | 2019 | 44 | 0.160 |
Why?
| | Pilocarpine | 1 | 2018 | 7 | 0.160 |
Why?
| | Liver | 2 | 2018 | 1634 | 0.160 |
Why?
| | Quinolones | 1 | 2020 | 97 | 0.160 |
Why?
| | Autoantibodies | 3 | 2023 | 1345 | 0.160 |
Why?
| | Bayes Theorem | 2 | 2018 | 329 | 0.160 |
Why?
| | Drug Prescriptions | 1 | 2020 | 239 | 0.150 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 91 | 0.150 |
Why?
| | Metabolomics | 2 | 2021 | 521 | 0.150 |
Why?
| | Medical History Taking | 1 | 2019 | 114 | 0.150 |
Why?
| | Nocturnal Myoclonus Syndrome | 1 | 2018 | 5 | 0.150 |
Why?
| | Research Design | 3 | 2019 | 928 | 0.150 |
Why?
| | Ophthalmic Solutions | 1 | 2018 | 66 | 0.150 |
Why?
| | Tomography | 1 | 2018 | 21 | 0.150 |
Why?
| | Specimen Handling | 2 | 2020 | 155 | 0.150 |
Why?
| | Hypoxia | 2 | 2018 | 957 | 0.150 |
Why?
| | C-Reactive Protein | 5 | 2021 | 362 | 0.150 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2018 | 16 | 0.150 |
Why?
| | Histones | 1 | 2023 | 535 | 0.150 |
Why?
| | Aptamers, Nucleotide | 1 | 2019 | 73 | 0.150 |
Why?
| | Metformin | 1 | 2021 | 276 | 0.150 |
Why?
| | Age Factors | 4 | 2018 | 2894 | 0.150 |
Why?
| | Symptom Assessment | 1 | 2019 | 119 | 0.150 |
Why?
| | Ocular Hypertension | 1 | 2018 | 61 | 0.150 |
Why?
| | Trabecular Meshwork | 1 | 2018 | 77 | 0.140 |
Why?
| | Respiration Disorders | 1 | 2018 | 69 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 178 | 0.140 |
Why?
| | Maternal Exposure | 1 | 2019 | 138 | 0.140 |
Why?
| | Logistic Models | 6 | 2019 | 1840 | 0.140 |
Why?
| | Pulmonary Artery | 3 | 2013 | 1015 | 0.140 |
Why?
| | Chorioamnionitis | 1 | 2017 | 36 | 0.140 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 1075 | 0.140 |
Why?
| | Clofazimine | 1 | 2017 | 14 | 0.140 |
Why?
| | Labor, Induced | 1 | 2017 | 32 | 0.140 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2016 | 18 | 0.140 |
Why?
| | Labor, Obstetric | 1 | 2017 | 52 | 0.140 |
Why?
| | Glaucoma, Open-Angle | 1 | 2018 | 95 | 0.140 |
Why?
| | Social Class | 1 | 2018 | 204 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 250 | 0.130 |
Why?
| | Fusobacterium | 1 | 2016 | 2 | 0.130 |
Why?
| | Haemophilus | 1 | 2016 | 4 | 0.130 |
Why?
| | Fusobacterium Infections | 1 | 2016 | 6 | 0.130 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2017 | 101 | 0.130 |
Why?
| | Diastole | 2 | 2013 | 130 | 0.130 |
Why?
| | Haemophilus Infections | 1 | 2016 | 28 | 0.130 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 323 | 0.130 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2018 | 217 | 0.130 |
Why?
| | Machine Learning | 1 | 2019 | 316 | 0.130 |
Why?
| | Attention | 3 | 2016 | 393 | 0.130 |
Why?
| | Esophagitis | 1 | 2016 | 65 | 0.130 |
Why?
| | Cataract Extraction | 1 | 2016 | 76 | 0.130 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 364 | 0.130 |
Why?
| | Antipsychotic Agents | 1 | 2017 | 184 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2019 | 452 | 0.120 |
Why?
| | Pediatric Obesity | 2 | 2019 | 488 | 0.120 |
Why?
| | Nose | 1 | 2015 | 55 | 0.120 |
Why?
| | Bronchi | 1 | 2016 | 231 | 0.120 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2019 | 288 | 0.120 |
Why?
| | Leukocyte L1 Antigen Complex | 3 | 2022 | 29 | 0.120 |
Why?
| | Pregnancy Trimester, First | 1 | 2015 | 125 | 0.120 |
Why?
| | Mutation | 3 | 2022 | 3344 | 0.120 |
Why?
| | Severity of Illness Index | 7 | 2019 | 2537 | 0.120 |
Why?
| | Phylogeny | 1 | 2018 | 789 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2012 | 1879 | 0.120 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 233 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 245 | 0.120 |
Why?
| | Registries | 2 | 2019 | 1767 | 0.120 |
Why?
| | Brain | 2 | 2019 | 2371 | 0.120 |
Why?
| | Chromosomes, Human, Pair 15 | 2 | 2012 | 53 | 0.120 |
Why?
| | Staphylococcal Infections | 2 | 2015 | 336 | 0.120 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1077 | 0.110 |
Why?
| | Hydrocortisone | 1 | 2016 | 267 | 0.110 |
Why?
| | RNA, Bacterial | 1 | 2015 | 174 | 0.110 |
Why?
| | Paranasal Sinuses | 1 | 2014 | 66 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 26 | 0.110 |
Why?
| | Affect | 1 | 2016 | 246 | 0.110 |
Why?
| | Limit of Detection | 1 | 2013 | 53 | 0.110 |
Why?
| | Evoked Potentials, Auditory | 2 | 2016 | 171 | 0.110 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 96 | 0.110 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2012 | 351 | 0.110 |
Why?
| | Saliva | 1 | 2015 | 187 | 0.110 |
Why?
| | Multivariate Analysis | 4 | 2019 | 1430 | 0.110 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.110 |
Why?
| | Database Management Systems | 1 | 2013 | 47 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2018 | 439 | 0.110 |
Why?
| | Forced Expiratory Volume | 3 | 2020 | 475 | 0.110 |
Why?
| | Sulfonamides | 1 | 2016 | 445 | 0.110 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2022 | 287 | 0.110 |
Why?
| | Fetus | 2 | 2018 | 699 | 0.110 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 90 | 0.110 |
Why?
| | Phosphorylcholine | 1 | 2013 | 17 | 0.110 |
Why?
| | Pneumonia, Bacterial | 1 | 2014 | 106 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2019 | 1018 | 0.110 |
Why?
| | Rhinitis | 1 | 2014 | 128 | 0.110 |
Why?
| | Receptors, Nicotinic | 3 | 2013 | 274 | 0.110 |
Why?
| | Nootropic Agents | 1 | 2013 | 27 | 0.110 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 191 | 0.110 |
Why?
| | Stress, Physiological | 1 | 2016 | 378 | 0.100 |
Why?
| | Parvovirus | 1 | 2012 | 13 | 0.100 |
Why?
| | Data Mining | 1 | 2014 | 100 | 0.100 |
Why?
| | Nasopharynx | 2 | 2023 | 61 | 0.100 |
Why?
| | User-Computer Interface | 1 | 2013 | 140 | 0.100 |
Why?
| | Bronchiolitis | 1 | 2013 | 81 | 0.100 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2012 | 9 | 0.100 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 234 | 0.100 |
Why?
| | Asthma | 2 | 2019 | 2029 | 0.100 |
Why?
| | Nicotinic Agonists | 2 | 2017 | 100 | 0.100 |
Why?
| | Sinusitis | 1 | 2014 | 174 | 0.100 |
Why?
| | Placenta | 1 | 2018 | 625 | 0.100 |
Why?
| | Propanolamines | 1 | 2012 | 90 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2015 | 993 | 0.100 |
Why?
| | Body Fluids | 1 | 2012 | 58 | 0.100 |
Why?
| | Bacterial Translocation | 1 | 2012 | 36 | 0.100 |
Why?
| | Elastin | 1 | 2012 | 78 | 0.100 |
Why?
| | Quality of Life | 2 | 2023 | 2353 | 0.100 |
Why?
| | Reference Values | 2 | 2010 | 742 | 0.100 |
Why?
| | Leukocyte Elastase | 3 | 2023 | 79 | 0.100 |
Why?
| | Cross-Sectional Studies | 6 | 2021 | 4405 | 0.090 |
Why?
| | HLA-DQ Antigens | 1 | 2012 | 174 | 0.090 |
Why?
| | Regional Blood Flow | 1 | 2013 | 424 | 0.090 |
Why?
| | Time Factors | 5 | 2021 | 6112 | 0.090 |
Why?
| | Eosinophilic Esophagitis | 1 | 2015 | 296 | 0.090 |
Why?
| | Administration, Oral | 3 | 2020 | 728 | 0.090 |
Why?
| | Granulocyte Colony-Stimulating Factor | 2 | 2022 | 71 | 0.090 |
Why?
| | HLA-DR Antigens | 1 | 2012 | 219 | 0.090 |
Why?
| | Sensitivity and Specificity | 4 | 2017 | 1691 | 0.090 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2012 | 287 | 0.090 |
Why?
| | Phenotype | 4 | 2022 | 2796 | 0.090 |
Why?
| | Esophagus | 1 | 2012 | 225 | 0.090 |
Why?
| | Immunoglobulin M | 2 | 2023 | 246 | 0.090 |
Why?
| | Tomography, Optical Coherence | 2 | 2023 | 130 | 0.090 |
Why?
| | Specific Gravity | 1 | 2010 | 11 | 0.090 |
Why?
| | Aorta | 1 | 2013 | 386 | 0.090 |
Why?
| | Odds Ratio | 3 | 2019 | 953 | 0.090 |
Why?
| | United States | 7 | 2023 | 12176 | 0.090 |
Why?
| | Autoimmunity | 2 | 2015 | 813 | 0.090 |
Why?
| | Genetic Association Studies | 1 | 2012 | 339 | 0.090 |
Why?
| | Gene Library | 1 | 2010 | 114 | 0.090 |
Why?
| | Staining and Labeling | 1 | 2010 | 134 | 0.080 |
Why?
| | Lung Injury | 1 | 2012 | 197 | 0.080 |
Why?
| | Regression Analysis | 3 | 2021 | 944 | 0.080 |
Why?
| | Heart Ventricles | 1 | 2013 | 712 | 0.080 |
Why?
| | Epoprostenol | 1 | 2009 | 133 | 0.080 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2009 | 81 | 0.080 |
Why?
| | Memory, Short-Term | 2 | 2008 | 225 | 0.080 |
Why?
| | Genotype | 4 | 2018 | 1760 | 0.080 |
Why?
| | Catheterization, Central Venous | 1 | 2009 | 83 | 0.080 |
Why?
| | Tonometry, Ocular | 2 | 2018 | 83 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2016 | 944 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2012 | 665 | 0.070 |
Why?
| | Schizophrenia, Childhood | 1 | 2007 | 3 | 0.070 |
Why?
| | Bacteremia | 1 | 2009 | 160 | 0.070 |
Why?
| | Linguistics | 1 | 2007 | 26 | 0.070 |
Why?
| | Child of Impaired Parents | 1 | 2007 | 40 | 0.070 |
Why?
| | Thoracic Surgery | 1 | 2008 | 106 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 2319 | 0.070 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 407 | 0.070 |
Why?
| | Culture | 1 | 2007 | 124 | 0.070 |
Why?
| | Memory Disorders | 1 | 2007 | 155 | 0.070 |
Why?
| | Inpatients | 1 | 2010 | 380 | 0.070 |
Why?
| | Coronary Artery Bypass, Off-Pump | 1 | 2006 | 15 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2009 | 429 | 0.060 |
Why?
| | Health Surveys | 1 | 2008 | 443 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 2 | 2017 | 2279 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2019 | 4689 | 0.060 |
Why?
| | Hospitalization | 2 | 2015 | 1749 | 0.060 |
Why?
| | Echocardiography | 3 | 2013 | 553 | 0.060 |
Why?
| | Hospitals, Veterans | 1 | 2006 | 244 | 0.060 |
Why?
| | Vision Tests | 1 | 2023 | 15 | 0.060 |
Why?
| | Equipment Design | 2 | 2018 | 508 | 0.060 |
Why?
| | Drug Resistance, Microbial | 1 | 2024 | 66 | 0.060 |
Why?
| | Spirometry | 2 | 2015 | 224 | 0.050 |
Why?
| | Neuroprotection | 1 | 2023 | 30 | 0.050 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2023 | 30 | 0.050 |
Why?
| | Systole | 2 | 2013 | 171 | 0.050 |
Why?
| | Dyneins | 1 | 2023 | 29 | 0.050 |
Why?
| | Vimentin | 1 | 2023 | 58 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2023 | 128 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1176 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2023 | 206 | 0.050 |
Why?
| | Complement Factor I | 1 | 2022 | 12 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 69 | 0.050 |
Why?
| | Calreticulin | 1 | 2022 | 24 | 0.050 |
Why?
| | Aqueous Humor | 1 | 2022 | 31 | 0.050 |
Why?
| | Antibodies, Bacterial | 1 | 2023 | 119 | 0.050 |
Why?
| | HMGB Proteins | 1 | 2022 | 15 | 0.050 |
Why?
| | Peptide Hydrolases | 1 | 2023 | 104 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 48 | 0.050 |
Why?
| | Animals | 8 | 2019 | 31695 | 0.050 |
Why?
| | Mice | 5 | 2019 | 14860 | 0.050 |
Why?
| | Aspergillus fumigatus | 1 | 2021 | 20 | 0.050 |
Why?
| | Immunoglobulin A | 1 | 2023 | 166 | 0.050 |
Why?
| | Smoke | 1 | 2023 | 123 | 0.050 |
Why?
| | Albumins | 1 | 2022 | 89 | 0.050 |
Why?
| | Capsulorhexis | 1 | 2021 | 8 | 0.050 |
Why?
| | Bacterial Load | 1 | 2021 | 58 | 0.050 |
Why?
| | Diagnosis, Differential | 2 | 2019 | 1342 | 0.050 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2012 | 190 | 0.050 |
Why?
| | Choroid | 1 | 2021 | 47 | 0.050 |
Why?
| | Antibiotics, Antitubercular | 1 | 2021 | 34 | 0.050 |
Why?
| | Fibrinogen | 1 | 2022 | 154 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2023 | 923 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2023 | 2762 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 385 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2022 | 155 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2017 | 1660 | 0.050 |
Why?
| | Lenses, Intraocular | 1 | 2021 | 42 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1736 | 0.050 |
Why?
| | Leptin | 1 | 2022 | 210 | 0.050 |
Why?
| | Systems Biology | 1 | 2021 | 54 | 0.040 |
Why?
| | Symptom Flare Up | 1 | 2020 | 38 | 0.040 |
Why?
| | Mycobacterium avium Complex | 1 | 2021 | 92 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2019 | 2565 | 0.040 |
Why?
| | Vitrectomy | 1 | 2020 | 57 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2012 | 811 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 220 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 38 | 0.040 |
Why?
| | Serum Amyloid A Protein | 1 | 2019 | 29 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 133 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 1945 | 0.040 |
Why?
| | Patient Acuity | 1 | 2019 | 42 | 0.040 |
Why?
| | Interleukin-8 | 2 | 2012 | 237 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 347 | 0.040 |
Why?
| | Antitubercular Agents | 1 | 2021 | 169 | 0.040 |
Why?
| | Electroencephalography | 2 | 2013 | 362 | 0.040 |
Why?
| | Western World | 1 | 2019 | 6 | 0.040 |
Why?
| | Protective Factors | 1 | 2019 | 87 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2021 | 440 | 0.040 |
Why?
| | Exercise Test | 2 | 2012 | 544 | 0.040 |
Why?
| | Cognition Disorders | 2 | 2017 | 476 | 0.040 |
Why?
| | Respiratory Rate | 1 | 2019 | 18 | 0.040 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 4620 | 0.040 |
Why?
| | Rats | 3 | 2012 | 4958 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2020 | 300 | 0.040 |
Why?
| | Coinfection | 1 | 2020 | 120 | 0.040 |
Why?
| | Prognosis | 3 | 2012 | 3328 | 0.040 |
Why?
| | Cardiac Catheterization | 2 | 2013 | 534 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 411 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2023 | 770 | 0.040 |
Why?
| | Norway | 1 | 2018 | 36 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 117 | 0.040 |
Why?
| | Oximetry | 1 | 2019 | 81 | 0.040 |
Why?
| | Proteome | 1 | 2022 | 339 | 0.040 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2018 | 18 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2014 | 1796 | 0.040 |
Why?
| | Axial Length, Eye | 1 | 2018 | 9 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 580 | 0.040 |
Why?
| | Corneal Pachymetry | 1 | 2018 | 14 | 0.040 |
Why?
| | Exfoliation Syndrome | 1 | 2018 | 10 | 0.040 |
Why?
| | Pseudophakia | 1 | 2018 | 11 | 0.040 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 93 | 0.040 |
Why?
| | Incidence | 2 | 2018 | 2311 | 0.040 |
Why?
| | Refraction, Ocular | 1 | 2018 | 30 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 100 | 0.040 |
Why?
| | Likelihood Functions | 1 | 2018 | 126 | 0.040 |
Why?
| | Bifidobacterium | 1 | 2017 | 21 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2023 | 1139 | 0.040 |
Why?
| | Polysomnography | 1 | 2018 | 135 | 0.040 |
Why?
| | Genes, rRNA | 1 | 2017 | 39 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3531 | 0.040 |
Why?
| | Biopsy | 2 | 2012 | 1036 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2013 | 1214 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2019 | 134 | 0.040 |
Why?
| | North America | 1 | 2018 | 256 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2022 | 640 | 0.040 |
Why?
| | Models, Biological | 2 | 2016 | 1620 | 0.040 |
Why?
| | Archaeal Proteins | 1 | 2017 | 45 | 0.040 |
Why?
| | Gene Expression | 1 | 2022 | 1421 | 0.040 |
Why?
| | Causality | 1 | 2017 | 103 | 0.040 |
Why?
| | Schizophrenic Psychology | 1 | 2017 | 86 | 0.030 |
Why?
| | Laser Coagulation | 1 | 2017 | 54 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 797 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2019 | 234 | 0.030 |
Why?
| | Parity | 1 | 2017 | 98 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2017 | 159 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 617 | 0.030 |
Why?
| | Family | 2 | 2012 | 589 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 15 | 0.030 |
Why?
| | Fetal Development | 1 | 2019 | 246 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2017 | 150 | 0.030 |
Why?
| | Chronic Disease | 2 | 2014 | 1578 | 0.030 |
Why?
| | Pregnancy Trimesters | 1 | 2016 | 13 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 7 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 8 | 0.030 |
Why?
| | Lactobacillus | 1 | 2015 | 24 | 0.030 |
Why?
| | Hair | 1 | 2016 | 65 | 0.030 |
Why?
| | Risk | 1 | 2018 | 812 | 0.030 |
Why?
| | Heart Rate | 1 | 2019 | 709 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 118 | 0.030 |
Why?
| | Problem Behavior | 1 | 2016 | 86 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Radiography | 1 | 2017 | 812 | 0.030 |
Why?
| | Brain Diseases | 1 | 2016 | 124 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 54 | 0.030 |
Why?
| | Cell Line | 2 | 2012 | 2635 | 0.030 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 176 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 32 | 0.030 |
Why?
| | Probability | 1 | 2016 | 289 | 0.030 |
Why?
| | Child Behavior Disorders | 1 | 2016 | 131 | 0.030 |
Why?
| | Stochastic Processes | 1 | 2015 | 64 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 18 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 26 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 32 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 149 | 0.030 |
Why?
| | Proteins | 1 | 2020 | 908 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 45 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 111 | 0.030 |
Why?
| | Larynx | 1 | 2014 | 47 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 51 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2021 | 1008 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 30 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 872 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 295 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 725 | 0.030 |
Why?
| | Overweight | 1 | 2017 | 471 | 0.030 |
Why?
| | Neuropsychological Tests | 2 | 2008 | 927 | 0.030 |
Why?
| | Comorbidity | 1 | 2018 | 1448 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2015 | 316 | 0.030 |
Why?
| | Atrial Function | 1 | 2013 | 11 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2014 | 175 | 0.030 |
Why?
| | Pilot Projects | 1 | 2017 | 1372 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 227 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 396 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1842 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 6 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 6 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.030 |
Why?
| | Perinatal Care | 1 | 2013 | 36 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 38 | 0.030 |
Why?
| | Cardiac Output | 1 | 2013 | 143 | 0.030 |
Why?
| | Rats, Inbred Lew | 1 | 2012 | 91 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 362 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2012 | 105 | 0.030 |
Why?
| | Plethysmography | 1 | 2012 | 103 | 0.030 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.030 |
Why?
| | Blood Glucose | 1 | 2021 | 1819 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2014 | 455 | 0.030 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2012 | 39 | 0.030 |
Why?
| | Leukocytes | 1 | 2013 | 276 | 0.030 |
Why?
| | Alprostadil | 1 | 2012 | 32 | 0.030 |
Why?
| | Physical Chromosome Mapping | 1 | 2012 | 16 | 0.020 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2013 | 133 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 55 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2012 | 157 | 0.020 |
Why?
| | Tricuspid Valve | 1 | 2012 | 25 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 142 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 62 | 0.020 |
Why?
| | Genotyping Techniques | 1 | 2012 | 69 | 0.020 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2012 | 46 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 372 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2012 | 57 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 106 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 62 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 287 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2012 | 136 | 0.020 |
Why?
| | Marijuana Smoking | 1 | 2015 | 224 | 0.020 |
Why?
| | Neurons | 1 | 2019 | 1279 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2012 | 294 | 0.020 |
Why?
| | Diet | 1 | 2018 | 1080 | 0.020 |
Why?
| | Genetic Markers | 1 | 2012 | 320 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 739 | 0.020 |
Why?
| | Bacteria, Anaerobic | 1 | 2010 | 20 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2012 | 299 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 620 | 0.020 |
Why?
| | Blood Flow Velocity | 1 | 2012 | 387 | 0.020 |
Why?
| | Exercise Tolerance | 1 | 2012 | 213 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2014 | 719 | 0.020 |
Why?
| | Cognition | 1 | 2017 | 988 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2016 | 736 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 246 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 840 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1072 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 498 | 0.020 |
Why?
| | Stroke Volume | 1 | 2012 | 504 | 0.020 |
Why?
| | Neurosecretory Systems | 1 | 2010 | 32 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 562 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 530 | 0.020 |
Why?
| | Rats, Inbred WKY | 1 | 2009 | 32 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 477 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2012 | 467 | 0.020 |
Why?
| | Hypertension | 1 | 2017 | 1056 | 0.020 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2009 | 37 | 0.020 |
Why?
| | Gram-Positive Bacteria | 1 | 2009 | 45 | 0.020 |
Why?
| | Receptors, Chemokine | 1 | 2009 | 44 | 0.020 |
Why?
| | Equipment Contamination | 1 | 2009 | 54 | 0.020 |
Why?
| | Gram-Negative Bacteria | 1 | 2009 | 66 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 367 | 0.020 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 79 | 0.020 |
Why?
| | Alcohol Drinking | 1 | 2015 | 651 | 0.020 |
Why?
| | Water | 1 | 2012 | 396 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 2014 | 497 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2012 | 676 | 0.020 |
Why?
| | Biodiversity | 1 | 2012 | 349 | 0.020 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2009 | 61 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 371 | 0.020 |
Why?
| | Brief Psychiatric Rating Scale | 1 | 2008 | 4 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2009 | 245 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 168 | 0.020 |
Why?
| | Depression | 1 | 2016 | 1133 | 0.020 |
Why?
| | Receptors, Cholinergic | 1 | 2008 | 41 | 0.020 |
Why?
| | Chemokines | 1 | 2009 | 216 | 0.020 |
Why?
| | Risk Adjustment | 1 | 2008 | 76 | 0.020 |
Why?
| | Nonverbal Communication | 1 | 2007 | 3 | 0.020 |
Why?
| | Pedigree | 1 | 2009 | 460 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2009 | 487 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2009 | 201 | 0.020 |
Why?
| | Postoperative Period | 1 | 2008 | 289 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2012 | 720 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3039 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2010 | 380 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2009 | 256 | 0.020 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 230 | 0.020 |
Why?
| | Monocytes | 1 | 2009 | 502 | 0.020 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 311 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2009 | 435 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2008 | 718 | 0.020 |
Why?
| | Blood Pressure | 1 | 2012 | 1538 | 0.020 |
Why?
| | Reaction Time | 1 | 2007 | 376 | 0.020 |
Why?
| | United States Department of Veterans Affairs | 1 | 2008 | 560 | 0.020 |
Why?
| | Hospitals | 1 | 2008 | 581 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1177 | 0.010 |
Why?
|
|
Wagner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|